Infusion-related HSR to systemic therapy is a serious adverse effect that significantly impacts disease management, quality of life, and life expectancy. Careful assessment of patients prior to initiating systemic therapy would enable the identification of patients at higher risk for HSR.

Occupational exposure to hazardous drugs such as antineoplastic agents is associated with health risks such as those associated with reproductive health and potential increased risk of cancer.

Recent advances in immunotherapies are changing the standard of care for patients with cancer.

Renal cell carcinoma (RCC) continues to have a significant health impact. With the emergence of these new therapies, it is increasingly important for oncology nurses to understand the data supporting all the available choices and the adverse effects associated with each of them.

LGBT individuals may show an increased incidence of certain cancers, but are less likely to receive regular medical care and standard cancer screenings. This lack of adequate medical care may be partially due to stigma and discrimination in health care settings.

Despite the known negative impacts of substance misuse and abuse among patients with cancer, these issues often go undiagnosed and/or untreated in patients with cancer.

Cardiovascular toxicities can be managed effectively with appropriate therapy if they are recognized early.